Advertisement

Social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsy

Published:February 21, 2017DOI:https://doi.org/10.1016/j.yebeh.2016.12.033

      Highlights

      • The relationship between social factors and epilepsy treatment with CBD is examined.
      • Social factors may affect access to care and treatment choices.
      • Higher age and lower income are associated with lower health rating.

      Abstract

      Social characteristics, such as socioeconomic status and race/ethnicity, play a role in the treatment and outcomes of patients with epilepsy (PWE), but little is known about how these factors affect patients receiving cannabidiol (CBD) to treat seizures. This exploratory study examined the sociodemographic profile of patients treated with CBD (n = 80) and associations between social factors and patient-centered outcomes – overall health status, Quality of Life in Epilepsy-89 (QOLIE-89), and Profile of Mood States (POMS) – in this population. Associations were examined using Pearson correlations and multiple ordinary-least-squares regression (alpha = 0.1). The sample was predominantly white (96%) and non-Hispanic/Latino (96%); 76% of patients had family incomes of $40,000+/year. Some patients/families reported experiencing food scarcity (13%), not being able to make ends meet (6%), or not being able to afford antiepileptic medications (8%). The patients' health ratings declined with age and income (p ≤ 0.014), and there was a statistically significant interaction (p < 0.055) between these variables: for example, a higher-income 10-year-old had a predicted health rating of 3 (“very good”), followed by a higher-income 40-year-old with a rating of 2 (“good”), a low-income 10-year-old with a rating of 1 (“fair”), and a low-income 40-year-old with a rating of 0 (“poor”). This is the first study reporting the social profile of patients taking pharmaceutical grade CBD for the treatment of epilepsy. The results suggest that despite free access to this treatment some patients may not be accessing CBD because of their socioeconomic situation or race/ethnicity. Larger, diverse samples and longitudinal data are needed to more accurately model social factors and patient-centered outcomes in PWE receiving CBD.
      This article is part of a Special Issue entitled “Cannabinoids and Epilepsy”.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Epilepsy & Behavior
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Szaflarski M.
        Social determinants of health in epilepsy.
        Epilepsy Behav. 2014; 41: 283-289
        • Loring D.W.
        • Meador K.J.
        • King D.W.
        • Hermann B.P.
        Relationship between quality of life variables and personality factors in patients with epilepsy and non-epileptic seizures.
        in: Gates J. Rowan A. Non-epileptic seizures. Butterworth Heinemann, Boston2000: 159-168
        • McNair D.
        • Lorr M.
        • Droppleman L.
        POMS: profile of mood states.
        EITS/Educational and Industrial Testing Service, San Diego, CA1992
      1. “Carly the catalyst”, B-Metro, Birmingham, Alabama; November 1 2016, p. 94–95. http://b-metro.com/carly-cbd-oil-seizures/30597/. [Accessed 29 November 2016].

        • World Health Organization
        Social determinants of health.
        (http://www.who.int/social_determinants/en/. Accessed)November 20 2016
        • Marmot M.
        Fair society, healthy lives: the Marmot review.
        ([Accessed 20 November 2016])
        • Szaflarski M.
        • Vaughn L.
        Deconstructing and addressing health disparities to build health equity.
        in: Murray M. Critical health psychology. 2nd ed. Palgrave Macmillan, New York, NY2014: 87-107
        • Burneo J.G.
        • Jette N.
        • Theodore W.
        • Begley C.
        • Parko K.
        • Thurman D.J.
        • et al.
        Disparities in epilepsy: report of a systematic review by the North American Commission of the International League Against Epilepsy.
        Epilepsia. 2009; 50: 2285-2295
        • Elliott J.P.
        • Istwan N.B.
        • Rhea D.J.
        • Desch C.N.
        • Stanziano G.J.
        The impact of ‘social determinants of health’ on epilepsy prevalence and reported medication use.
        Epilepsy Res. 2009; 84: 135-145
        • Hesdorffer D.C.
        • Tian H.
        • Anand K.
        • Hauser W.A.
        • Ludviggson P.
        • Olafsson E.
        • et al.
        Socioeconomic status is a risk factor for epilepsy in Icelandic adults but not in children.
        Epilepsia. 2005; 46: 1297-1303
        • Szaflarski M.
        • Szaflarski J.P.
        • Privitera M.D.
        • Ficker D.M.
        • Horner R.D.
        Racial/ethnic disparities in the treatment of epilepsy: what do we know? What do we need to know?.
        Epilepsy Behav. 2006; 9: 243-264
        • Theodore W.H.
        • Spencer S.S.
        • Wiebe S.
        • Langfitt J.T.
        • Ali A.
        • Shafer P.O.
        • et al.
        Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization.
        Epilepsia. 2006; 47: 1700-1722
        • Curry Jr., W.T.
        • Carter B.S.
        • Barker II, F.G.
        Racial, ethnic, and socioeconomic disparities in patient outcomes after craniotomy for tumor in adult patients in the United States, 1988–2004.
        Neurosurgery. 2010; 66 ([discussion 437-8]): 427-437
        • Englot D.J.
        • Ouyang D.
        • Garcia P.A.
        • Barbaro N.M.
        • Chang E.F.
        Epilepsy surgery trends in the United States, 1990–2008.
        Neurology. 2012; 78: 1200-1206
      2. Hickman D. Totten A. Berg A. Rader K. Goodman S. Newhouse R. The PCORI methodology report. PCORI methodology committee. 2013 ([Accessed 21 November 2016])
        • Deshpande P.R.
        • Rajan S.
        • Sudeepthi B.L.
        • Abdul Nazir C.P.
        Patient-reported outcomes: a new era in clinical research.
        Perspect Clin Res. 2011; 2: 137-144
      3. US Department of Health and Human Services and Food and Drug Administration Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims.
        ([Accessed 21 November 2016])
      4. National Institutes of Health. Health measures: transforming how health is measured.
        ([Accessed 21 November 2016])
        • Acquadro C.
        • Berzon R.
        • Dubois D.
        • Leidy N.K.
        • Marquis P.
        • Revicki D.
        • et al.
        Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) harmonization group meeting at the Food and Drug Administration, February 16, 2001.
        Value Health. 2003; 6: 522-531
        • Szaflarski J.P.
        • Hughes C.
        • Szaflarski M.
        • Ficker D.M.
        • Cahill W.T.
        • Li M.
        • et al.
        Quality of life in psychogenic nonepileptic seizures.
        Epilepsia. 2003; 44: 236-242
        • Szaflarski J.P.
        • Szaflarski M.
        • Hughes C.
        • Ficker D.M.
        • Cahill W.T.
        • Privitera M.D.
        Psychopathology and quality of life: psychogenic non-epileptic seizures versus epilepsy.
        Med Sci Monit. 2003; 9: CR113-CR118
        • Szaflarski M.
        • Cubbins L.A.
        Self-reported health in Poland and the United States: a comparative analysis of demographic, family and socioeconomic influences.
        Health (London). 2004; 8: 5-31
        • Idler E.L.
        • Benyamini Y.
        Self-rated health and mortality: a review of twenty-seven community studies.
        J Health Soc Behav. 1997; 38: 21-37
        • Ferraro K.F.
        • Farmer M.M.
        Utility of health data from social surveys: a review of the literature.
        Am Sociol Rev. 1999; 64: 303-315
        • Idler E.L.
        • Hudson S.V.
        • Leventhal H.
        The meanings of self-ratings of health: a qualitative and quantitative approach.
        Res Aging. 1999; 21: 458-476
        • Ross C.E.
        • Mirowsky J.
        Does employment affect health?.
        J Health Soc Behav. 1995; 36: 230-243
        • Burneo J.G.
        • Martin R.
        Reporting race/ethnicity in epilepsy clinical trials.
        Epilepsy Behav. 2004; 5: 743-745
        • Kobau R.
        • Zahran H.
        • Thurman D.J.
        • Zach M.M.
        • Henry T.R.
        • Schachter S.C.
        • et al.
        Epilepsy surveillance among adults–19 states, behavioral risk factor surveillance system, 2005.
        MMWR Surveill Summ. 2008; 57: 1-20
        • Baker G.A.
        • Hargis E.
        • Hsih M.M.
        • Mounfield H.
        • Arzimanoglou A.
        • Glauser R.
        • et al.
        Perceived impact of epilepsy in teenagers and young adults: an international survey.
        Epilepsy Behav. 2008; 12: 395-401
        • Institute of Medicine (U.S.). Committee on the Public Health Dimensions of the Epilepsies, and England MJ
        Epilepsy across the spectrum: promoting health and understanding.
        National Academies Press, Washington, DC2012